Tagged With BMS

Bristol-Myers Squibb is buying Celgene in a $74 billion deal


We're about to get some key lung cancer data -- and it could affect how hundreds of thousands of cancer patients are treated


Bristol-Myers Squibb just claimed 'a breakthrough in cancer research' -- but there's a catch



A pharma giant just made a $100 million move into a disease that's been called 'one of the next epidemic-level chronic diseases'


A new kind of treatment is working better than chemotherapy in some lung cancer patients


One failed study shows just how fiercely competitive a new field of cancer therapy is